Okayama, Japan

Toshimasa Katagiri

This inventor holds 1 USPTO granted patent. Top assignee: Japan Energy Corporation. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshimasa Katagiri. Retrieved from https://idiyas.com/inventor/toshimasa-katagiri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Toshimasa Katagiri

Introduction

Toshimasa Katagiri is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on chemical compounds.

Latest Patents

One of his key patents is related to 1-arylpyrimidine derivatives and their pharmaceutical applications. This invention involves compounds represented by a specific general formula, which includes variations where R1 can be hydrogen, alkyl, or aralkyl. This patent showcases his expertise in developing new chemical entities that may have therapeutic uses.

Career Highlights

Toshimasa Katagiri is associated with Japan Energy Corporation, where he has been able to apply his knowledge and skills in a corporate setting. His work has contributed to advancements in the pharmaceutical industry, particularly in the development of new drugs.

Collaborations

He has collaborated with notable colleagues such as Yoshiaki Isobe and Junko Umezawa, which has further enriched his research and development efforts.

Conclusion

Toshimasa Katagiri's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor in Japan. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…